Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

05 June 2014: Lab/In Vitro Research  

Bacterial tick-borne diseases caused by Bartonella spp., Borrelia burgdorferi sensu lato, Coxiella burnetii, and Rickettsia spp. among patients with cataract surgery

Tomasz Chmielewski ABCDEFG , Joanna Brydak-Godowska ABCDEFG , Beata Fiecek ABCDEFG , Urszula Rorot BDF , Elżbieta Sędrowicz BDF , Małgorzata Werenowska BDF , Dorota Kopacz BDF , Agata Hevelke BDF , Magdalena Michniewicz BDF , Dariusz Kęcik ACDEG , Stanisława Tylewska-Wierzbanowska ACDEG

DOI: 10.12659/MSM.890149

Med Sci Monit 2014; 20:927-931

0 Comments

Abstract

BACKGROUND: Clinical data have shown that tick-borne diseases caused by Borrelia burgdorferi sensu lato, Bartonella spp., Coxiella burnetii, and Rickettsia spp. can affect the central nervous system, including the eye. The aim of this study was to establish a relationship between the incidence of cataract and evidence of bacterial infections transmitted by ticks.

MATERIAL AND METHODS: Fluid with lenticular masses from inside of the eye and blood from 109 patients were tested by PCR and sequencing. Sera from patients and the control group were subjected to serological tests to search specific antibodies to the bacteria.

RESULTS: Microbiological analysis revealed the presence of Bartonella sp. DNA in intraoperative specimens from the eye in 1.8% of patients. Serological studies have shown that infections caused by B. burgdorferi sensu lato and Bartonella sp. were detected in 34.8% and 4.6% of patients with cataract surgery, respectively.

CONCLUSIONS: Presence of DNA of yet uncultured and undescribed species of Bartonella in eye liquid indicates past infection with this pathogen. Specific antibodies to B. burgdorferi sensu lato and Bartonella sp. are detected more frequently in patients with cataract compared to the control group. This could indicate a possible role of these organisms in the pathological processes within the eyeball, leading to changes in the lens. Further studies are needed to identify Bartonella species, as well as to recognize the infectious mechanisms involved in cataract development.

Keywords: Aged, 80 and over, Bacteria - metabolism, Bacterial Infections - microbiology, Bartonella - physiology, Borrelia burgdorferi - physiology, Cataract - microbiology, Cataract Extraction, Coxiella burnetii - physiology, Rickettsia - physiology, Seroepidemiologic Studies, Tick-Borne Diseases - microbiology

Background

An increased number of bacterial tick-borne disease cases have been reported in Poland in recent years. These are caused by Borrelia burgdorferi sensu lato, Bartonella spp., Coxiella burnetii, and Rickettsia spp. Clinical symptoms of tick-borne diseases can vary, depending on the affected system (osteoarticular, nervous, gastrointestinal, or cardiovascular). Some patients do not notice contact with a tick and the clinical course of acute infection could be mild. The possibility of infection with Bartonella spp. can also be associated with a scratch or bite by cats and the penetration of bacteria with the saliva through minor skin damage. This pathogen is detected in approximately 10% of cats in Poland [1]. Uveitis in the course of infection with Bartonella spp. was observed in some of these animals, as well as the presence of Bartonella spp. DNA in the aqueous humor [2].

Clinical data have shown that tick-borne diseases can affect the central nervous system, including the eye. Borrelia burgdorferi sensu lato is a cause of conjunctivitis, keratitis, uveitis, and retinal infection (macular edema and vasculitis). These symptoms are frequent findings in neuroborreliosis patients [3]. Optic neuritis, meningitis encephalitis, and paralysis of the oculomotor nerve have been reported in 3.5% patients with Q fever [4,5]. Retinal vascular involvement may present different clinical pictures: branch retinal artery occlusion, cystoid macular edema, serous retinal detachment, and hypofluorescent choroidal spots in patients with Rickettsia spp. infections [6]. The ocular manifestations of CSD (cat-scratch disease) are different: chronic ulcerative conjunctivitis associated with lymphadenopathy (referred to as Parinaud oculoglandular syndrome [POGS], neuroretinitis, sub-retinal lesions, retinitis, and intermediate uveitis. Some of these infections can be self-limiting or asymptomatic illnesses [7,8].

The aim of this study was to establish a relationship between the incidence of cataract and bacterial infections transmitted by ticks caused by microorganisms such as Borrelia burgdorferi sensu lato, Bartonella spp., Coxiella burnetii, and Rickettsia spp. Patients with cataract, without ocular inflammation (uveitis, retinitis), and without symptoms of infectious diseases were included in the study group.

Material and Methods

DNA PREPARATION:

A volume of 100 μl of fluid with lenticular masses and blood were taken for DNA extraction. The QIAamp Tissue kit (QIAGEN Gmbh, Hilden, Germany) was used according to the manufacturer’s recommendations. DNA samples were stored at −20°C.

PCR:

Extracted DNA was tested by PCR to detect fragments of genes characteristic for Borrelia burgdorferi sensu lato, Bartonella spp., Coxiella burnetii, and Rickettsia spp. using appropriate primer pairs [9–12]. The reaction mixtures of 50 μl contained 10 mM Tris-HCl, 50 mM KCl, 2.5 mM MgCl2, 0.1% gelatin, 200 μM dNTPs, 50 pmol of each primer, and 1.5 U Gold Taq DNA polymerase (Perkin-Elmer Cetus, USA). An aliquot of 5 μl of DNA template was added to each reaction mixture. The cycling conditions were as follows: 3 min at 95°C, followed by 40 cycles of 1 min of denaturation at 95°C, 1 min of annealing at 47°C to 59°C (depending on the starters used), 1 min of elongation at 72°C, and finally 7 min of elongation at 72°C. PCRs were performed in a Mastercycler gradient apparatus (Eppendorf AG, Germany). Each run of PCR test included positive (DNA from the collection of strains) and negative controls (water). All amplicons were analyzed by electrophoresis in 1.5% agarose gel stained with ethidium bromide.

SEQUENCING:

For purification of PCR products, the QIAquick PCR purification kit (QIAGEN Gmbh, Hilden, Germany) was used according to the manufacturer’s protocol. All amplicons were sequenced with the ABI 377 DNA Analyzer (Applied Biosystem, USA) according to the manufacturer’s recommendations. Sequences were edited using Autoassembler software (Applied Biosystem, USA) and identified using BLAST software by comparison with sequences available in GenBank.

SEROLOGY:

Antibodies to B. burgdorferi IgM and IgG were tested with ELISA test with recombinant antigens (DRG-Medtek, Germany). Positive results were confirmed by Western blot method with Anti-Borrelia-EUROLINE-WB IgM and Anti-Borrelia-EUROLINE-WB IgG (EUROIMMUN, Germany). Results were interpreted as seropositive according to criteria of the German Society of Hygiene and Microbiology (www.dghm.org/red/index.html?cname=MIQ). Levels of Bartonella spp. IgG antibodies were determined by indirect immunofluorescence assay (Bartonella IFA IgG; Focus diagnostics, USA) with Vero cells infected with B. henselae and B. quintana strains as antigens. IgG titer of ≥64 to at least 1 of the pathogens was considered as positive.

Levels of serum IgG antibodies to phase I and II C. burnetii antigens were assayed by indirect immunofluorescence method with Coxiella burnetii I+II IFA IgG/IgM/IgA kit (Vircell, Spain). Serum titer ≥64 for IgG was interpreted as positive.

IgG Rickettsia spp. antibodies were detected with microimmunofluorescence (MIF). A 2-step procedure was used for Rickettsia spp. antibody evaluation. For the detection and differentiation of antibodies specific to typhus and spotted fever groups, inactivated R. typhi and R. rickettsii antigens were used (Rickettsia IFA IgG, Focus diagnostic, USA). Screening was performed at 1:16 dilution.

STATISTIC ANALYSIS:

Statistic analysis (chi-square test and Fisher’s exact test) was done using the WinPepi 2.69 statistical program (Abramson JH [2011] WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiologic Perspectives & Innovations 2011, 8: 1 [available on the Internet at www.epiperspectives.com/content/8/1/]).

Results

Specific IgG serum antibodies to Bartonella sp. antigen were detected in 39 patients (35.8%). Among them, 2 (1.8%) patients had serum antibodies in a titer of 512, 3 patients had antibodies in a titer of 256 (2.8%), 6 patients had antibodies in a titer of 128 (5.5%), and 28 (25.7%) patients had antibodies in a titer of 64.

IgM and IgG antibodies to B. burgdorferi sl. were detected in 14 (12.8%) and 19 (17.4%) serum samples, respectively. Both classes of antibodies were detected in 5 samples (4.6%). IgG antibodies to Coxiella burnetii in titer of 64 was detected in 1 case (0.9%) (Table 1). IgG antibodies to spotted fever group Rickettsiae were not detected.

Specific IgG antibodies to B. henselae antigen were detected in 28 (28%) persons from the control group (blood donors) but in low titers of 64 (27 persons) and 128 (1 person). Specific antibodies to B. burgdorferi sl. were detected in sera taken from 12 blood donors: IgM were detected in 8 persons and IgG in 4 persons. All sera were seronegative to C. burnetii and Rickettsia spp. antigens.

DNA of Bartonella sp. was detected in the fluids taken from the eyeball from 2 seronegative patients. DNA of this pathogen was not detected in blood samples. These 2 sequences of gltA gene showed 99% identity with the gltA gene fragment amplicon of uncultured Bartonella sp. clone AS050 and clone AS071 (GenBank accession no. JQ695835.1 and JQ695834.1). The closest relative to the officially recognized species is B. clarridgeiae strain BCF02 (94% identity). DNA of other studied pathogens was not detected.

No intra- or post-operative complications were observed. Patients with positive serologic or PCR results for infectious agents studied did not have any symptoms of current infection.

Discussion

Diseases of the eye can affect many structures from tissue in the orbital cavity to uveitis and retina. Fungi, bacteria, viruses, protozoa, and systemic and autoimmune diseases may be etiologic agents of inflammation. The diagnosis of abnormalities in the retina and uveitis, involves puncture of the anterior chamber and/or vitreous to search for a specific pathogen, especially in difficult cases. PCR followed by sequencing clearly demonstrates the presence of the infectious factor causing vascular inflammation. Analysis of aqueous humor and/or vitreous is one of the procedures in the diagnosis of ocular inflammation and retinal or vascular membrane diseases [13–16]. It may also be used in experimental studies [17,18]. These are not routinely performed, due to possible complications after puncture of the anterior chamber or vitreous such as hemorrhage, detachment of the retina, and exacerbation of inflammation. Previous reports have suggested that inflammation in the eyeball may occur in the course of infections such as bartonellosis (cat-scratch disease – CSD), Lyme disease, Q fever or rickettsioses [3–8]. In Poland, testing for the presence of these infections is performed sporadically in patients with blurred vision.

Serological studies have shown that antibodies to B. burgdorferi sensu lato and Bartonella sp. are detected significantly more frequently in patients with cataracts in comparison with the control group. The approximate time of infection in these cases is difficult to determine. Titers of specific IgG antibodies to Bartonella sp. may remain positive for 2 years after disease onset [19]. Much longer periods of persistence of IgM and/or IgG antibodies (a few decades) are observed in Lyme disease [20,21]. In the surgical patients there was no evidence of inflammation in the eye and they did not report a history of infectious diseases in the past. Symptomatic cat-scratch disease in humans is rare and is observed more often in subclinical infection. Establishment of eye changes in the course of infection is likely to be related to the immune status of the host and the pathogenicity of the strain [22,23].

The ability to collect material from the anterior chamber during cataract surgery from patients without concomitant inflammation allowed us to detect the presence of Bartonella sp. DNA in 2 patients (1.8%). Common variable immunodeficiency was diagnosed in 1 of them. In these cases, antibodies to this pathogen were not detected. This indicates that infection could have occurred many years earlier and DNA of bacteria survived in the eyeball tissues.

Bartonella is a Gram-negative intracellular parasite that multiplies in erythrocytes and epithelial cells. It may spread to every organ of the host organism with the circulating blood. The presence of DNA in the eyeball suggests unknown route and time of contact with the pathogen (subclinical infection after being bitten by a tick or scratched by a cat). Bacteria reached the eyeball through blood vessels, probably through blood ciliary artery anterior to the anterior chamber of the eye (aqueous humor), without causing inflammation. Lens and aqueous humor are devoid of blood vessels (filtration); therefore, Bartonella cannot be eliminated after passing through these structures and most probably can be detected even several years after infection.

Processes of immunological tolerance associated with the phenomenon of anterior chamber-associated immune deviation (ACAID) seem to be the most likely protective mechanism against inflammation in the eye. This cascade of events is induced by introducing antigens into the anterior chamber. ACAID is maintained by stimulating the activity of tissue-specific suppressor cells: lymphocytes CD4+, CD8+, and CD25+ (called T regulatory cells [-Treg]), involvement of several cytokines, MSH, VIP, indoleamine, somatostatin, IL-4, IL-10, and TGF-2. The process of immune tolerance of the eye is also regulated by various organ-building cells, such as pigment epithelial cells of the ciliary body and retinal pigment epithelium. These have been shown to inhibit the activation of Th1 cells. Pigment epithelium releases a number of cytokines involved in ACAID, including TGFβ, thrombospondin and PGE2. Corneal endothelial cells also have a protective role in ACAID, releasing a number of suppressing substances to the lymphocytes (CD46, CD55, and CD59), and also those promoting apoptosis (Fas ligand) [24–27].

DNA of Bartonella sp. is stable and can be detected in the tissues long after infection. For example, dental pulp from the teeth of cats and dogs was used for the PCR detection of Bartonella sp. in animals buried for a year [28]. Dental pulp has been also proposed as a suitable tissue sample for the identification of pathogenic B. quintana. DNA was detected in the dental pulp extracted from the tooth of a homeless patient 6 months after he had been bacteremic [29]. In the literature, the case of 45-year-old man presenting with progressively worsening vitreitis of 1-week duration has been described. Vitrectomy and analysis of the vitrectomy specimens revealed inflammatory cells and necrotic debris 3 years later. PCR analysis of the vitreous fluid sample demonstrated the presence of B. henselae DNA [30].

Conclusions

Microbiological analysis revealed the presence DNA of Bartonella spp. in intraoperative specimens from the eye in 1.8% of patients. The presence of bacterial DNA in eye tissues indicates past infection with this pathogen. Serological studies have shown that infections caused by B. burgdorferi sensu lato and Bartonella sp. are detected more frequently in patients with cataract surgery compared to the control group. These facts could indicate a possible role of these organisms in the “inflammatory processes” within the eyeball, leading to changes in the lens. Further research is needed to elucidate this topic more completely.

References

1. Podsiadły E, Tylewska-Wierzbanowska S: Post Mikrobiol, 2008; 47; 275-81 [in Polish]

2. Lappin MR, Kordick DL, Breitschwerdt EB: J Feline Med Surg, 2000; 2; 61-68, pmid: 11716593

3. Mora P, Carta A, Ocular manifestations of Lyme borreliosis in Europe: Int J Med Sci, 2009; 6; 124-25, pmid: 19319228

4. Shaked Y, Samra Y, Q fever meningoencephalitis associated with bilateral abducens nerve paralysis, bilateral optic neuritis and abnormal cerebrospinal fluid findings: Infection, 1989; 17; 394-95, pmid: 2613330

5. Bernit E, Pouget J, Janbon F, Neurological involvement in acute Q fever: a report of 29 cases and review of the literature: Arch Intern Med, 2002; 162; 693-700, pmid: 11911724

6. El Matri L, Ocular manifestations of rickettsiosis: Retinal involvement an treatment: Int J Med Sci, 2009; 6; 128, pmid: 19319230

7. Ormerod LD, Dailey JP, Ocular manifestations of cat-scratch disease: Curr Opin Ophthalmol, 1999; 10; 209-16, pmid: 10537781

8. Chi SL, Stinnett S, Eggenberger E, Clinical characteristics in 53 patients with cat scratch optic neuropathy: Ophthalmology, 2012; 119; 183-87, pmid: 21959368

9. Podsiadly E, Karbowiak G, Tylewska-Wierzbanowska S: Clin Microbiol Infect, 2009; 15; 328-29, pmid: 19793116

10. Roux V, Rydkina E, Eremeeva M, Citrate synthase gene comparison, a new tool for phylogenetic analysis, and its application for the rickettsiae: Int J Syst Bacteriol, 1997; 47; 252-61, pmid: 9103608

11. Fournier PE, Raoult D, Comparison of PCR and serology assays for early diagnosis of acute Q fever: J Clin Microbiol, 2003; 41; 5094-98, pmid: 14605144

12. Chmielewski T, Fiett J, Gniadkowski M, Improvement to laboratory recognition of Lyme borreliosis with the combination of culture and PCR methods: Mol Diagn, 2003; 7; 155-62, pmid: 15068385

13. Muthiah MN, Michaelides M, Child CS, Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK: Br J Ophthalmol, 2007; 91; 1452-55, pmid: 17504853

14. Moshfeghi DM, Dodds EM, Couto CA, Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis: Ophthalmology, 2004; 111; 716-25, pmid: 15051204

15. Bhoomibunchoo C, Ratanapakorn T, Sinawat S, Infectious endophthalmitis: review of 420 cases: Clin Ophthalmol, 2013; 7; 247-52, pmid: 23403798

16. Stunf S, Petrovec M, Žigon N, High concordance of intraocular antibody synthesis against the rubella virus and Fuchs heterochromic uveitis syndrome in Slovenia: Mol Vis, 2012; 18; 2909-14, pmid: 23233792

17. Noma H, Funatsu H, Mimura T, Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion: Eur J Ophthalmol, 2010; 20; 402-9, pmid: 19967679

18. Cheung CM, Vania M, Ang M, Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy: Mol Vis, 2012; 18; 830-37, pmid: 22511846

19. Metzkor-Cotter E, Kletter Y, Avidor B, Long-term serological analysis and clinical follow-up of patients with cat scratch disease: Clin Infect Dis, 2003; 37; 1149-54, pmid: 14557957

20. Feder HM, Gerber MA, Luger SW: Clin Infect Dis, 1992; 15; 788-93, pmid: 1445977

21. Hilton E, Tramontano A, DeVoti J, Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis: J Clin Microbiol, 1997; 35; 774-76, pmid: 9041433

22. Fontenelle JP, Powell CC, Hill AE: J Feline Med Surg, 2008; 10; 41-46, pmid: 17719256

23. Resto-Ruiz S, Burgess A, Anderson BE: DNA Cell Biol, 2003; 22; 431-40, pmid: 12906736

24. Taylor AW, Kaplan HJ, Ocular immune privilege in the year 2010: ocular immune privilege and uveitis: Ocul Immunol Inflamm, 2010; 18; 488-92, pmid: 21091058

25. Streilein JW, Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation: J Leukoc Biol, 2003; 74; 179-85, pmid: 12885934

26. Taylor AW, Ocular immune privilege: Eye, 2009; 23; 1885-89, pmid: 19136922

27. Gregory MS, Repp AC, Hawlina M, Membrane Fas ligand activates innate immunity and terminates ocular immune privilege: J Immunol, 2002; 169; 2727-35, pmid: 12193747

28. Aboudharam G, Vu DL, Davoust B: Microb Pathog, 2005; 38; 47-51, pmid: 15652295

29. Aboudharam G, Fournier PE, Drancourt M: Eur J Clin Microbiol Infect Dis, 2004; 23; 920-22, pmid: 15558347

30. Goldstein DA, Mouritsen L, Friedlander S: Clin Infect Dis, 2001; 33; 718-21, pmid: 11486295

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750